🇺🇸 Aripiprazole tablets in United States

253 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 253

Most-reported reactions

1. Drug Ineffective — 44 reports (17.39%)
2. Product Use In Unapproved Indication — 40 reports (15.81%)
3. Off Label Use — 39 reports (15.42%)
4. Anxiety — 20 reports (7.91%)
5. Dizziness — 20 reports (7.91%)
6. Weight Increased — 19 reports (7.51%)
7. Condition Aggravated — 18 reports (7.11%)
8. Drug Interaction — 18 reports (7.11%)
9. Restlessness — 18 reports (7.11%)
10. Akathisia — 17 reports (6.72%)

Source database →

Frequently asked questions

Is Aripiprazole tablets approved in United States?

Aripiprazole tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Aripiprazole tablets in United States?

Chengdu Kanghong Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.